Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complete Pathological Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT07127497
What this trial is testing

Clinical Study on the Safety and Relationship of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma

Who this might be right for
Pathological Complete ResponseRectal CancerNeoadjuvant Chemoimmunotherapy
The First Affiliated Hospital of Anhui Medical University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06817525
What this trial is testing

Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBC

Who this might be right for
Triple-negative Breast Cancer
Henan Cancer Hospital 64
Testing effectiveness (Phase 2)Ended earlyNCT01570868
What this trial is testing

Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Accelerated Phase (AP)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 51
Testing effectiveness (Phase 2)Study completedNCT01914900
What this trial is testing

Preoperative TPF Chemotherapy in Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer

Who this might be right for
Locally Advanced Resectable Oral Cavity Squamous Cell Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 14
Not applicableStudy completedNCT01490853
What this trial is testing

Follow-up of Ph+ Chronic Myleoid Leukemia Patients in Complete Cytogenetic Response With Interferon Based Therapy

Who this might be right for
Chronic Myeloid Leukemia
Università degli Studi di Brescia 116
Not applicableStudy completedNCT03981705
What this trial is testing

Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer

Who this might be right for
TN ER-/PR-/HER2- Breast CancerTriple Negative Breast CancerHER2-positive Breast Cancer+1 more
Masonic Cancer Center, University of Minnesota 8
Large-scale testing (Phase 3)UnknownNCT00297570
What this trial is testing

Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy

Who this might be right for
Leukemia, Myeloid, Philadelphia-Positive
Sheba Medical Center 90
Testing effectiveness (Phase 2)WithdrawnNCT01843179
What this trial is testing

Sulindac for Patients With AML

Who this might be right for
Acute Myeloid Leukemia
Massachusetts General Hospital
Testing effectiveness (Phase 2)Study completedNCT01818063
What this trial is testing

Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerHER2-negative Breast CancerProgesterone Receptor-negative Breast Cancer+5 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 9
Post-approval studies (Phase 4)Not Yet RecruitingNCT07093931
What this trial is testing

Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer

Who this might be right for
Breast Cancer
Shandong Cancer Hospital and Institute 468
Testing effectiveness (Phase 2)Looking for participantsNCT07007052
What this trial is testing

Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
French Innovative Leukemia Organisation 33
Early research (Phase 1)Not Yet RecruitingNCT06743555
What this trial is testing

Surgery After Verifying Existing Disease in Locally Advanced Operable Lung Cancer: A Pilot Study

Who this might be right for
Non-Small Cell Lung CancerImmunotherapyNeoadjuvant Therapy+2 more
Centre hospitalier de l'Université de Montréal (CHUM) 14
Testing effectiveness (Phase 2)Study completedNCT01349478
What this trial is testing

The Effects of Passive Gait Training in Complete Motor Spinal Cord Injury (SCI)

Who this might be right for
Motor Complete Spinal Cord Injury
Dr. Gabriel Zeilig 11
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07397442
What this trial is testing

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer, AdenocarcinomaRectal Cancer Stage IIRectal Cancer Stage III
Beijing Friendship Hospital 19
Not applicableWithdrawnNCT01956513
What this trial is testing

Contribution of MRI in the Evaluation of Apparent Diffusion Coefficient and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer

Who this might be right for
Assess the Variation of Apparent Diffusion Coefficient
Centre Jean Perrin
Post-approval studies (Phase 4)Study completedNCT02097004
What this trial is testing

Study of Therapeutic Vaccination With Intensified Schedule Plus Pegasys Dual Therapy on Chronic Hepatitis B Infection

Who this might be right for
Hepatitis B, Chronic
Seoul National University Hospital 111
Not applicableStudy completedNCT01464008
What this trial is testing

The Predictive Value of On-treatment Virological Response for Sustained Virological Response in Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Beijing Ditan Hospital 297
Testing effectiveness (Phase 2)Looking for participantsNCT07507318
What this trial is testing

Chidamide Maintenance for MRD-Positive Double-Expressor DLBCL in First Complete Remission

Who this might be right for
Diffuse Large B-Cell Lymphoma
Rong Tao 69
Not applicableStudy completedNCT07426653
What this trial is testing

Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Using Machine Learning Models.

Who this might be right for
Breast Cancer
Florence Nightingale Hospital, Istanbul 298
Testing effectiveness (Phase 2)Study completedNCT00545688
What this trial is testing

Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer.

Who this might be right for
Breast Cancer
Hoffmann-La Roche 417
Next Page